US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Franklin Genomic Advancements ETF

42.34

-0.7701-1.79%

Post-market: 42.350.0101+0.02%16:10 EDT

Volume:2K

Turnover:64.58K

Market Cap:31.75M

PE:- -

High:42.35

Open:42.35

Low:42.34

Close:43.11

52wk High:43.11

52wk Low:29.32

Shares:750.00K

Float Shares:750.00K

Volume Ratio:2.57

T/O Rate:0.20%

Dividend:0.14

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Annexon Biosciences (ANNX) and Guardant Health (GH)

Natera Inc : TD Cowen Raises Target Price to $325 from $280

THOMSON REUTERS

XOMA Royalty Corporation Completes Merger with Ligand Pharmaceuticals

Ligand Closes Acquisition of XOMA Royalty for $39 Per Share Cash

XOMA Royalty Announces Closing of Its Acquisition by Ligand

THOMSON REUTERS

Press Release: Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY), Madrigal Pharmaceuticals (MDGL) and Krystal Biotech (KRYS)

Krystal Biotech Inc : Bofa Global Research Raises Price Objective to $396 from $364

THOMSON REUTERS

Guardant Health is Maintained at Buy by Canaccord Genuity

Guardant Health price target raised to $205 from $135 at Canaccord

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Krystal Biotech (KRYS) and Denali Therapeutics (DNLI)

Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to Azurity Pharmaceuticals

Agenus Signs Deal to Sell Up to $340 Million Worth of Securities; Shares Up Pre-Bell

MT Newswires Live

Krystal Biotech Stock And 2 Biotech Names With Pipeline Catalysts

Simply Wall St.

Is Natera (NTRA) Fully Valued As Signatera Wins EU IVDR Certification?

Simply Wall St.

July 2026's Top Stock Picks Estimated To Be Trading Below Fair Value

Simply Wall St.

Genetic Technologies Faces ASX Deadlines Amid Long-Term Trading Suspension

Cancer Blood Screen Spac's Merger is Delayed by Test's Results

Guardant Health to Report Q2 2026 Results After Market Close, Host Conference Call

Guardant Health is Maintained at Overweight by Morgan Stanley

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/HELX/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HELX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","market":"US","secType":"STK","nameCN":"Franklin Genomic Advancements ETF","latestPrice":42.3399,"timestamp":1787601600000,"preClose":43.11,"halted":0,"volume":1524,"hourTrading":{"tag":"盘后","latestPrice":42.35,"preClose":42.3399,"latestTime":"16:10 EDT","volume":10,"amount":423.399,"timestamp":1787602205257,"change":0.0101,"changeRate":0.000239,"amplitude":0},"delay":0,"changeRate":-0.01786360473208071,"floatShares":750000,"shares":750000,"eps":0,"marketStatus":"Closed","change":-0.7701,"latestTime":"08-24 16:00:00 EDT","open":42.35,"high":42.35,"low":42.3399,"amount":64576,"amplitude":0.000234,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"exchange":"CBOE","adjPreClose":43.11,"sharesOutstanding":650000,"nav":43.201,"aum":32400497.63,"dividendRate":0.003361,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":42.35,"preClose":42.3399,"latestTime":"16:10 EDT","volume":10,"amount":423.399,"timestamp":1787602205257,"change":0.0101,"changeRate":0.000239,"amplitude":0},"volumeRatio":2.565656,"impliedVol":0.2459,"impliedVolPercentile":0.8606},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","floatShares":750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.565656,"shares":750000,"dividePrice":0.1423,"high":42.35,"amplitude":0.000234,"preClose":43.11,"low":42.3399,"week52Low":29.32,"pbRate":"--","week52High":43.11,"institutionHeld":0,"latestPrice":42.3399,"eps":0,"divideRate":0.003361,"volume":1524,"delay":0,"ttmEps":0,"open":42.35,"prevYearClose":36.3062,"prevWeekClose":43.11,"prevMonthClose":38.8312,"prevQuarterClose":39.9651,"fiveDayClose":41.1366,"twentyDayClose":38.8569,"sixtyDayClose":34.2035},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HELX\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HELX","amount":0.14334,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Franklin Genomic Advancements ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-08","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-08"},{"market":"US","date":"2021-12-30","symbol":"HELX","amount":0.003935,"defaultRemindTime":1640874600000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000},{"market":"US","date":"2021-12-13","symbol":"HELX","amount":0.114148,"defaultRemindTime":1639405800000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2021-12-21","payableDate":"2021-12-14","currency":"USD","type":"dividend","dateTimestamp":1639371600000},{"market":"US","date":"2020-12-14","symbol":"HELX","amount":0.005005,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2020-12-23","payableDate":"2020-12-15","currency":"USD","type":"dividend","dateTimestamp":1607922000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HELX\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-23","value":0.005005,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-21","value":0.114148,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.003935,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-08","value":0.14334,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HELX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HELX\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651452589","title":"Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Annexon Biosciences (ANNX) and Guardant Health (GH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651452589","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651452589?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:40","pubTimestamp":1784112028,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Merck & Company (MRK), Annexon Biosciences (ANNX) ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-annexon-biosciences-annx-and-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-annexon-biosciences-annx-and-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756168.USD","BK4139","LU1934455194.USD","IE00BLSP4452.SGD","SG9999002224.SGD","IE00B4R5TH58.HKD","LU1037948541.HKD","LU2089984988.USD","ANNX","LU0006306889.USD","SG9999001440.SGD","LU0130102774.USD","LU1093756325.SGD","HELX","LU1057294990.SGD","FHLC","LU0861579265.USD","LU2125909247.SGD","LU0965508806.USD","LU1116320737.USD","LU2361044865.SGD","SG9999014559.SGD","IE00BJT1NW94.SGD","LU2023250843.SGD","LU1974910355.USD","LU0942090050.USD","LU0965509010.AUD","LU2491050071.SGD","LU0266013472.USD","GNOM","LU0203347892.USD","LU0211331839.USD","LU0648001328.SGD","LU2360032135.SGD","LU0106261372.USD","LU1929549753.HKD","IE0002141913.USD","BK4516","LU0265550946.USD","LU1035773651.USD","BK4588","EKG","SG9999014567.USD","LU1941712264.USD","LU0477156953.USD","LU1585245621.USD","LU1061106388.HKD","BK4551","BK4533","GDOC","BK4550","PPH","IE00BJJMRZ35.SGD","LU0238689110.USD","IE000M9KFDE8.USD","IE00BLSP4239.USD","IE00B1BXHZ80.USD","LU1066053197.SGD","LU1989771016.USD","LU2468319806.SGD","LU1917777945.USD","LU1066051498.USD","LU1162221912.USD","LU0868494708.USD","SG9999013999.USD","LU1989772923.USD","LU2361044949.HKD","PAWZ","LU0859254822.USD","IE00B2B36J28.USD","BK4534","SG9999002232.USD","LU2106854487.HKD","LU1989772840.SGD","BK4585","BMED","LU2461242641.AUD","BK4196","IHE","LU0208291251.USD","LU0234572021.USD","LU0122379950.USD","LU2125909593.SGD","LU1201861249.SGD","IE0009355771.USD","LU1023059063.AUD","LU2361045086.USD","LU1934455277.USD","LU0098860793.USD","RXL","IE00BSNM7G36.USD","LU0320765646.SGD","SG9999014575.USD","LU2112291526.USD","LU1069347547.HKD","LU2491049909.HKD","LU0320765992.SGD","LU1571399168.USD","LU0289739699.SGD","IXJ","LU1941712348.USD","LU0965509283.SGD","LU0868494617.USD","LU0265550359.USD","LU0985320562.USD","JDOC","FTXH","LU1037948897.HKD","HRTS","LU1430594728.SGD","SG9999015341.SGD","LU0124676726.USD","BK4007","LU0058720904.USD","LU0070302665.USD","LU0130517989.USD","LU1923622614.USD","LU0965509101.SGD","LU2125154935.USD","SG9999015358.SGD","PTH","IE00BFTCPJ56.SGD","SGXZ57979304.SGD","LU0109394709.USD","LU1291159041.SGD","LU2491050154.USD","SG9999001176.USD","LFSC","LU1934455863.HKD","LU0203345920.USD","LU2324357040.USD","LU2023250504.SGD","LU1699723380.USD","LU1983299246.USD","LU1116320901.HKD","IE00BBT3K403.USD","LU2433249047.HKD","LU2125154778.USD","BK4535","LU0689626769.HKD","SG9999001176.SGD","LU0320765489.SGD","VHT","LU1066051225.USD","BK4559","IYH","LU1066051811.HKD","LU2357627491.SGD","MRK","LU0889565916.HKD","GH","IE00BN8TJ469.HKD","SG9999014542.SGD","LU0432979614.USD","LU0980610538.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651451247","title":"Natera Inc : TD Cowen Raises Target Price to $325 from $280","url":"https://stock-news.laohu8.com/highlight/detail?id=2651451247","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651451247?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:08","pubTimestamp":1784110087,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H0QG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0345770993.USD","BK4139","LU1064131342.USD","LU2324357040.USD","LU0053671581.USD","LU2065171311.SGD","LU2065170008.USD","LU2065169927.USD","LU0963586101.USD","LU1988902786.USD","LU0106261612.USD","LU2065171402.SGD","LU0012050646.USD","GNOM","NTRA","LU2264538146.SGD","LU2065731478.USD","LU0345770308.USD","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651453502","title":"XOMA Royalty Corporation Completes Merger with Ligand Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2651453502","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651453502?lang=en_us&edition=fundamental","pubTime":"2026-07-15 16:01","pubTimestamp":1784102486,"startTime":"0","endTime":"0","summary":"The latest update is out from XOMA Royalty Corporation ( ($XOMA) ). On July 14, 2026, XOMA Royalty Corporation completed its previously announced m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xoma-royalty-corporation-completes-merger-with-ligand-pharmaceuticals?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xoma-royalty-corporation-completes-merger-with-ligand-pharmaceuticals?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009354923.USD","XOMA","HELX","BK4139","LGND","LU0566484027.USD","BK4007","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651485106","title":"Ligand Closes Acquisition of XOMA Royalty for $39 Per Share Cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2651485106","media":"Reuters","labels":["corporation","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651485106?lang=en_us&edition=fundamental","pubTime":"2026-07-14 21:01","pubTimestamp":1784034064,"startTime":"0","endTime":"0","summary":"Ligand closes acquisition of XOMA Royalty for $39 per share cashLigand Pharmaceuticals completed its acquisition of XOMA Royalty, buying all outstanding common shares.Stockholders received USD 39 per ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL5l2sMG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","LGND","SG9999014005.SGD","BK4007","LU0566484027.USD","IE00BKPKM429.USD","HELX","SG9999014039.USD","IE00BGHQF748.EUR","LU2210149790.SGD","NDAQ","IE00BN0W2V16.EUR","LU2210150020.SGD","LU2095319765.USD","IE00B3QW5Z07.USD","BK4585","BK4139","IE00BN0W2T93.GBP","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2W23.USD","XOMA","IE0009354923.USD","BK4588","IE00B64PRP62.GBP","SG9999014021.USD","LU1559883803.SGD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651069611","title":"XOMA Royalty Announces Closing of Its Acquisition by Ligand","url":"https://stock-news.laohu8.com/highlight/detail?id=2651069611","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651069611?lang=en_us&edition=fundamental","pubTime":"2026-07-14 21:00","pubTimestamp":1784034006,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nTUA9RFBHY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LGND","BK4139","BK4007","LU0566484027.USD","HELX","LU1559883803.SGD","XOMA","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651106139","title":"Press Release: Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=2651106139","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651106139?lang=en_us&edition=fundamental","pubTime":"2026-07-14 21:00","pubTimestamp":1784034000,"startTime":"0","endTime":"0","summary":"Acquisition adds seven commercial products including VABYSMO(R) (faricimab-svoa), OJEMDA(TM) (tovorafenib), and MIPLYFFA(R) (arimoclomol), and more than 100 development and commercial-stage assets, cr","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0300736492.USD","LU0345780281.USD","LU0368265764.SGD","LU0630314457.HKD","HELX","SG9999001143.SGD","LU0566484027.USD","R","LU0345780521.USD","LU1559883803.SGD","SG9999002521.SGD","BK4604","BK4585","03160","B","BK4555","LU0330918003.SGD","IE0009354923.USD","TM","LU0788109121.HKD","BK4139","LU0496367417.USD","BK4588","LU0498741890.SGD","LU0345780950.USD","LU0612318971.USD","LU1023059493.AUD","BK4017","BK4232","BK4099","LU0654597011.USD","LU0055631609.USD","BU","BK4161","LGND","XOMA","BK4022","LU0075056555.USD","LU0300736062.USD","LU0345781412.USD","LU0788108826.HKD","LU0724618789.USD","LU1430597077.USD","BK4007","LU0612318385.USD","LU0498741114.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105476","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY), Madrigal Pharmaceuticals (MDGL) and Krystal Biotech (KRYS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105476","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105476?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:40","pubTimestamp":1784032839,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alnylam Pharma (ALNY), Madrigal Pharmaceuticals (M...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-alnylam-pharma-alny-madrigal-pharmaceuticals-mdgl-and-krystal-biotech-krys-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-alnylam-pharma-alny-madrigal-pharmaceuticals-mdgl-and-krystal-biotech-krys-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","BK4139","PBE","LU0889565916.HKD","HCSG","KRYS","BK4137","BK4548","BK4581","LU0128526141.USD","ALNY","PSCH","HELX","XBI","MDGL","LU0114720955.EUR","LU0029874061.USD","LU0882574055.USD","XLV","LU0320765992.SGD","BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651810563","title":"Krystal Biotech Inc : Bofa Global Research Raises Price Objective to $396 from $364","url":"https://stock-news.laohu8.com/highlight/detail?id=2651810563","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651810563?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:31","pubTimestamp":1784032302,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nFWN43G10M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HELX","KRYS","BK4139","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651103511","title":"Guardant Health is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2651103511","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651103511?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:05","pubTimestamp":1784030700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings(END) Dow Jones NewswiresJuly 14, 2026 08:05 ET","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","EKG","HELX","GH","LFSC","GNOM","LU0320765992.SGD","BK4585","BK4551","BK4196","BK4535","GDOC","LU0889565916.HKD","LU0109394709.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651177472","title":"Guardant Health price target raised to $205 from $135 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2651177472","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651177472?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:56","pubTimestamp":1784026600,"startTime":"0","endTime":"0","summary":"Canaccord analyst Kyle Mikson raised the firm’s price target on Guardant Health (GH) to $205 from $135 and keeps a Buy rating on the shares. The fi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-205-from-135-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-205-from-135-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","EKG","BK4551","PTH","GH","LU0889565916.HKD","LU0109394709.USD","BK4585","BK4588","LU0320765992.SGD","BK4196","HELX","GNOM","BK4535","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651092112","title":"Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Krystal Biotech (KRYS) and Denali Therapeutics (DNLI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651092112","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651092112?lang=en_us&edition=fundamental","pubTime":"2026-07-13 22:01","pubTimestamp":1783951267,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Genmab (GMAB), Krystal Biotech (KRYS) and Denali Therapeutics (DN...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-genmab-gmab-krystal-biotech-krys-and-denali-therapeutics-dnli-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-genmab-gmab-krystal-biotech-krys-and-denali-therapeutics-dnli-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4585","PSCH","DNLI","LU0128526141.USD","BK4548","LU0029874061.USD","BK4535","HELX","BK4139","LABU","XBI","BK4581","XLV","BK4588","KRYS","BK4137","GMAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651436111","title":"Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to Azurity Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2651436111","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651436111?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:00","pubTimestamp":1783944000,"startTime":"0","endTime":"0","summary":"Will create publicly traded advanced clean energy company focused on modular carbon-free energy, green hydrogen, critical materials and industrial decarbonization Business Combination expected to prov","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/13/3326126/32419/en/Matinas-BioPharma-Announces-Strategic-Business-Combination-with-GH-Power-to-Create-Publicly-Traded-Advanced-Clean-Energy-and-Green-Hydrogen-Company-Signs-Definitive-Agreement-to-Se.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4234","GDOC","HELX","EKG","GNOM","LNC","LU0109394709.USD","PTH","GSFP","PW","BK4596","LU0889565916.HKD","HYDR","BK4157","BK4535","BK4551","DBB","ICLN","AEIS","LU0320765992.SGD","CTEC","LFSC","BK4585","BK4084","IE00B19Z4B17.USD","IE0031619046.USD","LU1815336091.USD","GH","LU0757428866.USD","CCSO","IE00B66KJ199.SGD","BK4196","IE00B7SZL793.SGD","BK4588","BK4162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651869115","title":"Agenus Signs Deal to Sell Up to $340 Million Worth of Securities; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2651869115","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651869115?lang=en_us&edition=fundamental","pubTime":"2026-07-13 18:47","pubTimestamp":1783939664,"startTime":"0","endTime":"0","summary":"Agenus  has signed an agreement to sell up to $340 million worth of securities, the company said Monday.The company said the deal includes a private placement of about $85 million in upfront gross proceeds, with an option to receive up to an additional $255 million upon full exercise of purchase warrants.The purchase price was at a premium to Agenus' closing price on Friday, it said.The financing was led by Commodore Capital, with participation from RA Capital Management, TCGX, Invus, and Ligand Pharmaceuticals , Agenus said.Agenus said that net proceeds will be used to advance its ROBBIN registrational phase 3 neoadjuvant trial in microsatellite-stable colon cancer.The private placement is expected to close on Wednesday, the company said.Shares of the company were up 17% in Monday's premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0566484027.USD","BK4139","HELX","AGEN","LU1559883803.SGD","LGND","IE0009354923.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651199377","title":"Krystal Biotech Stock And 2 Biotech Names With Pipeline Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2651199377","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651199377?lang=en_us&edition=fundamental","pubTime":"2026-07-13 12:44","pubTimestamp":1783917888,"startTime":"0","endTime":"0","summary":"The latest headlines around AstraZeneca, from its £207b valuation to its multibillion dollar R&D and expansion plans, show how a single company’s choices on investment, geography, and pipeline risk can ripple across the wider pharmaceuticals and biotechnology sector. For investors, this news creates both potential opportunity and fresh questions about concentration in China, future drug exclusivity, and the impact of trial setbacks. This article looks at 3 large cap stocks from our...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/krystal-biotech-stock-and-2-biotech-names-with-pipeline-cata","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-krys/krystal-biotech/news/krystal-biotech-stock-and-2-biotech-names-with-pipeline-cata","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0345770308.USD","HELX","LU0320765992.SGD","LU1988902786.USD","LU2324357040.USD","LU0345770993.USD","LU2065171311.SGD","KRYS","XBI","LU0154245673.USD","LU2065170008.USD","NTRA","PSCH","LU2264538146.SGD","BK4585","GNOM","LU0012050646.USD","BK4588","LU0889565916.HKD","LU0823416689.USD","LU1064131342.USD","LU0053671581.USD","BK4139","BK4581","LU0154245756.USD","LU2065731478.USD","LU0963586101.USD","LU2065171402.SGD","LU2065169927.USD","LU0109394709.USD","NBIX","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650335130","title":"Is Natera (NTRA) Fully Valued As Signatera Wins EU IVDR Certification?","url":"https://stock-news.laohu8.com/highlight/detail?id=2650335130","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650335130?lang=en_us&edition=fundamental","pubTime":"2026-07-11 04:44","pubTimestamp":1783716249,"startTime":"0","endTime":"0","summary":"Natera (NTRA) is back in focus after securing Class C certification under the European Union’s In Vitro Diagnostic Regulation for its Signatera cancer test, a regulatory milestone that is tied to long term EU market access.\nSee our latest analysis for Natera.\nThe IVDR milestone lands during a strong run for Natera’s stock, with a 30 day share price return of 26.49% and a 90 day share price return of 46.01%. The 1 year total shareholder return of 72.53% and very large 3 year total shareholder...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntra/natera/news/is-natera-ntra-fully-valued-as-signatera-wins-eu-ivdr-certif","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntra/natera/news/is-natera-ntra-fully-valued-as-signatera-wins-eu-ivdr-certif","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2324357040.USD","LU2065731478.USD","GNOM","HELX","LU2065170008.USD","LU1064131342.USD","LU2065171402.SGD","LU0012050646.USD","LU0053671581.USD","LU0963586101.USD","NTRA","DCF","BK4139","LU0345770993.USD","BK4156","LU0345770308.USD","LU1988902786.USD","LU2264538146.SGD","LU2065169927.USD","LU2065171311.SGD","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650290131","title":"July 2026's Top Stock Picks Estimated To Be Trading Below Fair Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2650290131","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650290131?lang=en_us&edition=fundamental","pubTime":"2026-07-11 01:08","pubTimestamp":1783703283,"startTime":"0","endTime":"0","summary":"Over the past year, the United States market has experienced a 19% increase, although it remained flat over the past week, with earnings projected to grow by 18% annually in the coming years. In this context of overall growth potential, identifying stocks that are currently trading below their fair value can offer investors opportunities for strong returns while aligning with future earnings expectations.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/4212000-choice1-main-header/1585186649420","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4212000-choice1-main-header/1585186649420"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/consumer-services/nyse-vik/viking-holdings/news/july-2026s-top-stock-picks-estimated-to-be-trading-below-fai","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-services/nyse-vik/viking-holdings/news/july-2026s-top-stock-picks-estimated-to-be-trading-below-fai","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BBT.AU","LU2065171402.SGD","JAN","LU1559883803.SGD","QTWO","BK4023","JAN.AU","BK4211","LU0077335932.USD","LU2065170008.USD","BK4142","PEJ","LU2264538146.SGD","LU0868494617.USD","IE0009354923.USD","IE0034390439.USD","PRM.AU","GNOM","PRM","IE00B66KJ199.SGD","BK4539","LU1064131342.USD","NTRA","LU0345770308.USD","VIK","LU2065731478.USD","PCOR","BK4207","HELX","LU0963586101.USD","BK4535","SLX","CECO","IE0031619046.USD","LU2065171311.SGD","VSXY","BK4109","BK4585","BBT","LU0566484027.USD","STLD","LAZ","PYZ","FRBT","BK4007","IE00B7SZL793.SGD","BK4225","LU0345770993.USD","BK7142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650074239","title":"Genetic Technologies Faces ASX Deadlines Amid Long-Term Trading Suspension","url":"https://stock-news.laohu8.com/highlight/detail?id=2650074239","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650074239?lang=en_us&edition=fundamental","pubTime":"2026-07-10 14:52","pubTimestamp":1783666376,"startTime":"0","endTime":"0","summary":"Genetic Technologies ( ($AU:GTG) ) has shared an update. Genetic Technologies Limited, a biotechnology company specializing in genetic testing and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genetic-technologies-faces-asx-deadlines-amid-long-term-trading-suspension?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genetic-technologies-faces-asx-deadlines-amid-long-term-trading-suspension?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","SYNB","XT","AGNG","FWD","HELX","BK4585","JDOC","RSPH","WDNA","BBP","DARP","BK4588","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650451974","title":"Cancer Blood Screen Spac's Merger is Delayed by Test's Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2650451974","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650451974?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:24","pubTimestamp":1783628640,"startTime":"0","endTime":"0","summary":"Call Thursday's cancer test results mixed.Thursday was the day set for shareholders to approve the merger of special-purpose acquisition company Perceptive Capital Solutions with cancer screening firm","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","BK4588","BK4196","LU0320765992.SGD","GH","PCSC","BK4551","BK4535","PTH","GNOM","LFSC","LU0889565916.HKD","BK4139","HELX","GRAL","LU0109394709.USD","BK4585","EKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650197453","title":"Guardant Health to Report Q2 2026 Results After Market Close, Host Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2650197453","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650197453?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:05","pubTimestamp":1783627546,"startTime":"0","endTime":"0","summary":"Guardant Health to report Q2 2026 results after market close, host conference callGuardant Health schedules second-quarter 2026 results for July 30, 2026.Conference call webcast set for July 30, 2026 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDL1VMHCJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","GNOM","GDOC","BK4535","BK4551","LU0320765992.SGD","EKG","GH","BK4196","LU0109394709.USD","LU0889565916.HKD","BK4585","PTH","HELX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650976358","title":"Guardant Health is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2650976358","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650976358?lang=en_us&edition=fundamental","pubTime":"2026-07-10 01:10","pubTimestamp":1783617000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings(END) Dow Jones NewswiresJuly 09, 2026 13:10 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4551","BK4588","EKG","LFSC","PTH","GH","GNOM","HELX","LU0889565916.HKD","BK4535","LU0109394709.USD","LU0320765992.SGD","GDOC","BK4196"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}